Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan L Roth

Showing results (431-440 of 450) with videos related to

Pageof 45
Sort By:
Nature|November 30, 2022
Structure-based design of bitopic ligands for the µ-opioid receptorAbdelfattah Faouzi, Haoqing Wang, Saheem A Zaidi, et al.
Science Advances|February 11, 2026
Structure-based design of an opioid receptor modulator for enhanced morphine analgesiaYue Wang, Ping Luo, Haiyan Xu, et al.
Cell|February 6, 2018
5-HT<sub>2C</sub> Receptor Structures Reveal the Structural Basis of GPCR PolypharmacologyYao Peng, John D McCorvy, Kasper Harpsøe, et al.
Plos One|March 11, 2016
In Vitro and In Vivo Characterization of the Alkaloid NuciferineMartilias S Farrell, John D McCorvy, Xi-Ping Huang, et al.
Nature|May 4, 2019
Publisher Correction: Structural basis of ligand recognition at the human MT<sub>1</sub> melatonin receptorBenjamin Stauch, Linda C Johansson, John D McCorvy, et al.
Angewandte Chemie (International Ed. in English)|March 3, 2015
A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)H Ümit Kaniskan, Magdalena M Szewczyk, Zhengtian Yu, et al.
Nature Neuroscience|July 8, 2020
Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeysYuji Nagai, Naohisa Miyakawa, Hiroyuki Takuwa, et al.
Nature Biotechnology|October 27, 2015
Comprehensive characterization of the Published Kinase Inhibitor SetJonathan M Elkins, Vita Fedele, Marta Szklarz, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Toward a Random Background for Ligand OptimizationXinyu Xu, Olivier Mailhot, Galen J Correy, et al.
Nature|November 18, 2021
Structure, function and pharmacology of human itch GPCRsCan Cao, Hye Jin Kang, Isha Singh, et al.
Pageof 45

Showing results (431-440 of 450) with videos related to

Sort By:
Pageof 45
Nature|November 30, 2022
Structure-based design of bitopic ligands for the µ-opioid receptorAbdelfattah Faouzi, Haoqing Wang, Saheem A Zaidi, et al.
Science Advances|February 11, 2026
Structure-based design of an opioid receptor modulator for enhanced morphine analgesiaYue Wang, Ping Luo, Haiyan Xu, et al.
Cell|February 6, 2018
5-HT<sub>2C</sub> Receptor Structures Reveal the Structural Basis of GPCR PolypharmacologyYao Peng, John D McCorvy, Kasper Harpsøe, et al.
Plos One|March 11, 2016
In Vitro and In Vivo Characterization of the Alkaloid NuciferineMartilias S Farrell, John D McCorvy, Xi-Ping Huang, et al.
Nature|May 4, 2019
Publisher Correction: Structural basis of ligand recognition at the human MT<sub>1</sub> melatonin receptorBenjamin Stauch, Linda C Johansson, John D McCorvy, et al.
Angewandte Chemie (International Ed. in English)|March 3, 2015
A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)H Ümit Kaniskan, Magdalena M Szewczyk, Zhengtian Yu, et al.
Nature Neuroscience|July 8, 2020
Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeysYuji Nagai, Naohisa Miyakawa, Hiroyuki Takuwa, et al.
Nature Biotechnology|October 27, 2015
Comprehensive characterization of the Published Kinase Inhibitor SetJonathan M Elkins, Vita Fedele, Marta Szklarz, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Toward a Random Background for Ligand OptimizationXinyu Xu, Olivier Mailhot, Galen J Correy, et al.
Nature|November 18, 2021
Structure, function and pharmacology of human itch GPCRsCan Cao, Hye Jin Kang, Isha Singh, et al.
Pageof 45